An increasing number of studies have shown that CD4+ T cells are susceptible to exhaustion and may contribute to the reactivation of the antitumour immune response after ICI treatment in multiple cancer types, including bladder cancer.10, 11. This evidence concerns the gene CD4 and urinary bladder carcinoma.